Silva Paul M

Silva Paul M is listed in filings as Director at Nurix Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 15, 2026, including 4 public disclosures. Recent filings connect the profile to Nurix Therapeutics, Inc. (NRIX) and Rapport Therapeutics, Inc. Common Stock (RAPP). The current snapshot covers public activity from Nov 7, 2024 to May 15, 2026. Reported amounts are shown as $495.6K to $237.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.